A retrospective study performed in a cohort of CD patients found that females carrying an FXR-1GT genotype had three times less FGF19 serum levels and had a higher risk of needing surgery, showing that impaired FXR signaling can be detrimental in IBD (56). Here, NR1H4 is linked to inflammatory bowel disease.